Pegaspargase
Common brands: Oncaspar, Methotrexate, Jylamvo, Otrexup, Rasuvo
Top reporter: Servier Pharmaceuticals Llc
Asparagine-specific Enzyme [EPC]Corticosteroid [EPC]Folate Analog Metabolic Inhibitor [EPC]Nucleoside Metabolic Inhibitor [EPC]Alkylating Drug [EPC]
12,050
Total Reports
5,244
Serious Reports
1,540
Death Reports
30
Reported Reactions
Death Report Ratio: High (12.78%)
Patient Demographics
Reported Adverse Reactions (30)
Side effects reported in FDA adverse event reports for Pegaspargase.
| # | Reaction | Reports | % of Total |
|---|---|---|---|
| 1 | FEBRILE NEUTROPENIA | 1,573 | |
| 2 | PYREXIA | 767 | |
| 3 | FEBRILE BONE MARROW APLASIA | 676 | |
| 4 | VOMITING | 597 | |
| 5 | NEUTROPENIA | 569 | |
| 6 | SEPSIS | 561 | |
| 7 | ABDOMINAL PAIN | 508 | |
| 8 | HYPOTENSION | 462 | |
| 9 | PANCREATITIS | 411 | |
| 10 | HYPERTRIGLYCERIDAEMIA | 406 | |
| 11 | THROMBOCYTOPENIA | 402 | |
| 12 | NAUSEA | 400 | |
| 13 | HYPERBILIRUBINAEMIA | 367 | |
| 14 | PNEUMONIA | 360 | |
| 15 | BACTERIAL INFECTION | 339 | |
| 16 | SEPTIC SHOCK | 335 | |
| 17 | OFF LABEL USE | 331 | |
| 18 | HYPERSENSITIVITY | 330 | |
| 19 | TACHYCARDIA | 330 | |
| 20 | MUCOSAL INFLAMMATION | 328 | |
| 21 | ANAEMIA | 308 | |
| 22 | HYPOFIBRINOGENAEMIA | 299 | |
| 23 | ALANINE AMINOTRANSFERASE INCREASED | 273 | |
| 24 | PANCYTOPENIA | 273 | |
| 25 | CLOSTRIDIUM DIFFICILE COLITIS | 267 | |
| 26 | VIRAL INFECTION | 259 | |
| 27 | HEADACHE | 257 | |
| 28 | ACUTE KIDNEY INJURY | 246 | |
| 29 | DIARRHOEA | 245 | |
| 30 | ANAPHYLACTIC REACTION | 235 |
Important Disclaimer
FDA adverse event reports are submitted voluntarily and do not prove causation. A reported reaction does not mean the drug caused it. Drugs with more users naturally have more reports. Always consult your doctor or pharmacist before making medication decisions.